News
Survey on change requests assessment by WHO
This survey aims to gather feedback on the updated PQDx 121 guidance, the new change request submission form, and the overall submission and assessment process.
Invitation to submit applications for WHO’s prequalification assessment
WHO is pleased to announce that the Prequalification of IVDs programme scope has been expanded to the following types of products:
New IVD prequalification listing
On 18th December the Loopamp MTBC Detection Kit manufactured by Eiken Chemical Co., Ltd. was prequalified.
Notice of Concern (NOC) for Meril Diagnostics Pvt Ltd Published
A Notice of Concern (NOC) has been published by the World Health Organization (WHO), through its Prequalification Unit (PQT), for Meril Diagnostics Pvt Ltd.
Active Pharmaceutical Ingredient (API) Prequalified
Levonorgestrel manufactured by Jiangsu Lianhuan Pharmaceutical Co., Ltd.
Rusan’s azithromycin tabl and Ipca’s albendazole tabl prequalified
WHO Prequalification Unit (PQT) added the below new products to its prequalified list:
Notice on Fee Adjustments for the WHO Prequalification Programme
Effective 1 January 2026, the WHO Prequalification Programme will introduce an annual 10% increase on all applicable fees that have remained unchanged since 2017.
First EUL to PQ transition of IVDs
For the first time, two SARS-CoV-2 antigen detection rapid tests have successfully transitioned from WHO’s Emergency Use Listing (EUL) to WHO Prequalification (PQ):
WHO webinar on changes to the PQ procedure for IVDs - 17 Dec 2025
On 17 December 2025 the Assessment of Medical Devices Team held a webinar for stakeholders to introduce changes which will be implemented to the prequalification assessment
WHO Prequalification Workshop for Chinese manufacturers of IVDs - Guangzhou 9-11 December 2025
WHO recently hosted a successful workshop in The Westin Guangzhou, Guangzhou, China, bringing together over
Emergency Use Listing of the 12th MPXV assay
The Monkeypox Virus (MPXV) Fast Real Time PCR Kit manufactured by Jiangsu Bioperfectus Technologies Co., Ltd.
First caffeine products for apnoea in pre-term infants prequalified
WHO Prequalification Unit (PQT) added the below new products to its prequalified list:
23nd Invitation to Manufacturers of Antimalarial Medicines to Submit an Expression of Interest (EOI) for Product Evaluation to the WHO Prequalification Unit (PQT)
The invitation to Manufacturers of Antimalarial Medicines to submit an Expression of Interest for Product Evaluation to t
40th Invitation of Active Pharmaceutical Ingredients (APIs)
The following API was deleted:
First primaquine dispersible tablets prequalified
WHO Prequalification Unit (PQT) added the below new products to its prequalified list:
WHO's Public Assessment Reports (WHOPARs) Updates
WHO’s Prequalification of In Vitro Diagnostics
During the week of 27–31 October 2025, the World Health Organization (WHO) publ
EUL Listing: MPXV IVD
Cowingene Monkeypox Typing Detection Kit, manufactured by Taizhou Cowingene Biotech Co., Ltd., has been listed under the WHO Emergency Use Listing (EUL).
&nb
Two HPV assays have been prequalified
These assays - Aptima HPV 16 18/45 Genotype Assay and the Aptima HPV Assay provide advanced nucleic acid amplification technology for detecting high-risk HPV type
Update on Nitrosamine Impurities
In September 2023, PQT/MED issued a call to manufacturers to revisit and update their risk assessments for Finished Pharmaceutical Products (FPP) containing APIs with vulnerable amine groups.
New EUL Listing: MPXV IVD
The PQT/AMD team has added a new product to the Emergency Use Listing (EUL):
WHO's Public Assessment Reports (WHOPARs) Updates
During the week of 20–24 October 2025, the World Health Organization (WHO) published updates to several WHO’s Public Assessment Reports (WHOPARs) on its In Vitro Diagnostics (IV
Two PQT Medicines workshops for manufacturers
The PQT Medicines 8th Annual Medicines Quality Workshop for Manufacturers will take place from 27 to 30 October 2025.
EUL listing of an additional MPXV test
In a continuing effort to best support the MPXV response, the Prequalification Unit has listed the Monkeypox Virus
WHO has listed an additional TB test
The World Health Organization (WHO) has prequalified the Xpert MTB/XDR test, a quality-assured molecular diagnostic tool that enables rapid drug susceptibility testing (DST) for tuberculosis (TB).
Additional HPV tests listing
WHO has prequalified two more products:
The BD Onclarity™ HPV Assay for the BD COR™ System is an amplified DNA test for the qualitative dete
Training for IVDs assessors for WHO Prequalification WHO Academy Lyon, 7-9 October 2025
A core component of the Prequalification assessment process relates to technical review of the product dossier and change requests.
First lenacapavirs prequalified
Gilead’s Lenacapavir Tablet and Injection Products Prequalified by WHO
PQ IVDs Newsletter Q3 2025
We are pleased to announce that the PQ IVDs Newsletter Issue 50 - Q3 2025 has just been released today.
WHO Expands IVD Prequalification Scope to Support TB Diagnosis
TB and drug-resistant TB remain underdiagnosed globally.
WHO's announcement on PQ performance evaluations for HPV assays
WHO adopting the fulfilment of Meijer’s 2009 criteria in independent evaluations as WHO’s prequalification independent performance evaluation component for HPV nucleic acid tests.
Incepta’s medroxyprogesterone susp for injection prequalified
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Annual UN meeting with manufacturer and suppliers: Updates on IVDs
The 2025 UNFPA-UNICEF-WHO Annual Meeting is taking place online from 29 September to 3 October 2025. The theme of the 2025 Joint Meeting was “Delivering in times of D
REGISTRATION OPEN - 2025 Joint UNICEF-UNFPA-WHO Meeting with Manufacturers and Suppliers
On behalf of the United Nations Population Fund (UNFPA), the United Nations Children Fund (UNICEF) and the World Health Organization (WHO), we invite you to the 2025 UNFPA-UNICEF-WHO Annual Meeting
New EUL product listed for IVD
On 17 September 2025, the Monkeypox Virus Lyo-PCR Kit, manufactured by Shanghai ZJ Bio-Tech Co., Ltd, was listed as an additional in vitro diagnostic under the Emergency Use Listi
AMA training
On 17, 18 and 19 September 2025, the WHO Prequalification Unit, Medicines Assessment Team is organizing a Training for African Assessors and EMP-TC Members under AMRH and the future African Medicin
New EUL listing
An additional in vitro diagnostic has been listed under the Emergency Use Listing procedure.
Strides' cycloserine prequalified
WHO Prequalification Unit (PQT) added the below new product to its prequalified list: